Innovating to advance science that matters

Skin conditions go far beyond the surface. They can have a profound impact on people's daily lives, affecting physical health, emotional wellbeing and social connections.

At Almirall, we are dedicated to medical dermatology. Through our in-house R&D capabilities and collaborations with leading strategic partners, we work to advance the scientific understanding of skin diseases and develop innovative solutions that address real patient needs.

Our pipeline focuses on areas with significant unmet medical needs, including immune-mediated diseases, non-melanoma skin cancer and rare dermatological conditions. At the same time, we are exploring next-generation technologies such as biologics, small molecules, bispecific antibodies, mRNA/LNP platforms and AI-enabled approaches to drive innovation in dermatology.

As a family-owned company, we take a long-term view, investing in scientific progress that can create lasting value for patients, healthcare professionals and the broader dermatology community.

Discover how we are helping shape the future of medical dermatology: https://www.almirall.com/innovation